Review: taking Fluoxetine hydrochloride and Subutex together


Summary

Drug interactions are reported among people who take Fluoxetine hydrochloride and Subutex together. This review analyzes the effectiveness and drug interactions between Fluoxetine hydrochloride and Subutex. It is created by eHealthMe based on reports of 131 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Fluoxetine hydrochloride and Subutex >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Fluoxetine Hydrochloride

Fluoxetine hydrochloride has active ingredients of fluoxetine hydrochloride. It is often used in depression. (latest outcomes from Fluoxetine hydrochloride 4,058 users)

Subutex

Subutex has active ingredients of buprenorphine hydrochloride. It is often used in drug dependence. (latest outcomes from Subutex 3,050 users)

On Jul, 23, 2016

131 people who take Fluoxetine Hydrochloride, Subutex are studied.


Number of reports submitted per year:

Fluoxetine hydrochloride and Subutex drug interactions.

Drug effectiveness over time:

Fluoxetine Hydrochloride:
  • < 1 month: 100.0% - (3 of 3 people)
  • 1 - 6 months: 0.0% - (0 of 6 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 3 people)
  • 2 - 5 years: 0.0% - (0 of 3 people)
  • 5 - 10 years: 25.0% - (1 of 4 people)
  • 10+ years: 12.0% - (1 of 8 people)
  • not specified: 0.0% - (0 of 0 people)
Subutex:
  • < 1 month: 85.0% - (6 of 7 people)
  • 1 - 6 months: 66.0% - (2 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (5 of 5 people)
  • 2 - 5 years: 50.0% - (2 of 4 people)
  • 5 - 10 years: 100.0% - (3 of 3 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 100.0% - (6 of 6 people)

Drug effectiveness by gender:

Fluoxetine Hydrochloride:
  • female: 23.0% - (4 of 17 people)
  • male: 10.0% - (1 of 10 people)
Subutex:
  • female: 83.0% - (15 of 18 people)
  • male: 90.0% - (9 of 10 people)

Drug effectiveness by age:

Fluoxetine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 0.0% - (0 of 3 people)
  • 30-39: 36.0% - (4 of 11 people)
  • 40-49: 20.0% - (1 of 5 people)
  • 50-59: 0.0% - (0 of 6 people)
  • 60+: 0.0% - (0 of 0 people)
Subutex:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 50.0% - (1 of 2 people)
  • 20-29: 50.0% - (2 of 4 people)
  • 30-39: 100.0% - (11 of 11 people)
  • 40-49: 80.0% - (4 of 5 people)
  • 50-59: 100.0% - (6 of 6 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • anxiety
  • mood swings
  • sleepiness
  • abdominal pain
  • affect lability
  • back pain
  • balance disorder
  • crying
  • depressed mood
  • depression
1 - 6 months:
  • thrombocytopenia
  • bone marrow failure
  • coagulopathy
  • endocarditis staphylococcal
  • hyponatraemia
  • melaena
  • pancytopenia
  • pulmonary embolism
  • purpura
  • renal failure
6 - 12 months:
  • abortion induced
  • congenital foot malformation
  • drug exposure during pregnancy
  • dysmorphism
  • syndactyly
1 - 2 years:
  • abortion spontaneous
  • drug exposure during pregnancy
  • hypoglycaemia
2 - 5 years:
  • abdominal cramps
  • constipation
  • adrenal insufficiency
  • appetite - decreased
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • hepatic enzyme increased
  • hepatitis
  • jaundice
  • weight loss - unintentional
5 - 10 years:
  • thrombocytopenia
  • acne cystic
10+ years:
  • depression
  • drowsiness
  • dry mouth
  • irritability
  • swallowing difficulty
  • vomiting
  • restlessness
  • sweating
not specified:
  • somnolence
  • pneumonia aspiration
  • vomiting
  • drug exposure during pregnancy
  • dry mouth
  • accidental overdose
  • injury
  • nausea
  • anxiety
  • decreased appetite

Most common drug interactions by gender *:

female:
  • somnolence
  • pneumonia aspiration
  • anxiety
  • dry mouth
  • vomiting
  • depression
  • drug exposure during pregnancy
  • abdominal pain
  • dyspnoea
  • foot deformity
male:
  • bone marrow failure
  • coagulopathy
  • endocarditis staphylococcal
  • hyponatraemia
  • melaena
  • pancytopenia
  • pulmonary embolism
  • purpura
  • renal failure
  • thrombocytopenia

Most common drug interactions by age *:

0-1:
  • drug withdrawal syndrome neonatal
  • anaemia neonatal
  • neutropenia neonatal
  • complications of maternal exposure to therapeutic drugs
  • gastro-oesophageal reflux disease
  • hepatomegaly
  • drug exposure during pregnancy
  • hypotonia neonatal
  • neonatal disorder
  • neonatal respiratory distress syndrome
10-19:
  • apgar score low
  • cyanosis neonatal
  • drug withdrawal syndrome neonatal
  • hypotonia neonatal
  • neonatal respiratory depression
20-29:
  • abdominal cramps
  • abnormal behaviour
  • abortion spontaneous
  • agitation
  • anxiety
  • constipation
  • death
  • decreased activity
  • dental caries
  • depression
30-39:
  • thrombocytopenia
  • abortion induced
  • bone marrow failure
  • coagulopathy
  • endocarditis staphylococcal
  • hyponatraemia
  • melaena
  • pancytopenia
  • pulmonary embolism
  • purpura
40-49:
  • confusional state
  • overdose
  • accident
  • cardiac disorder
  • coronary artery atherosclerosis
  • drug abuser
  • injury
  • international normalised ratio increased
  • renal arteritis
  • death
50-59:
  • dry mouth
  • vomiting
  • insomnia
  • abdominal pain
  • accidental overdose
  • acquired oesophageal web
  • altered state of consciousness
  • anxiety
  • arthralgia
  • bone disorder
60+:
  • pneumonia aspiration
  • somnolence
  • dermatitis

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Fluoxetine hydrochloride and Subutex?

Can you answer these questions?

More questions for: Fluoxetine hydrochloride, Subutex

You may be interested in these reviews

More reviews for: Fluoxetine hydrochloride, Subutex

On eHealthMe, Fluoxetine hydrochloride (fluoxetine hydrochloride) is often used to treat depression. Subutex (buprenorphine hydrochloride) is often used to treat drug dependence. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.